Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This drug is a sterile, nonpyrogenic solution containing 15 crystalline amino acids: alanine, valine, proline, phenylalanine, arginine, leucine, isoleucine, tyrosine, methionine, threonine, serine, glycine, histidine, tryptophan, and lysine hydrochloride. It is designed for intravenous administration as a component of parenteral nutrition to provide a source of nitrogen for protein synthesis. The formulation includes both essential and non-essential amino acids to help maintain nitrogen balance and prevent protein wasting in patients who cannot receive adequate nutrition via the oral or enteral routes. It is commonly used in clinical settings for patients with severe gastrointestinal disorders, major surgery, or critical illness. The specific use of lysine hydrochloride distinguishes this formulation from newer variants that utilize lysine acetate to reduce chloride load.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on amino acids.